Key terms
About STXS
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest STXS news
Mar 25
8:45am ET
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Mar 25
7:18am ET
Stereotaxis management to meet with Lake Street
Mar 18
6:35am ET
Stereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust Financials
Mar 05
8:43am ET
Stereotaxis price target raised to $4 from $3 at Lake Street
Mar 04
4:35pm ET
Stereotaxis announces regulatory submissions for MAGiC catheter in Europe, U.S.
Mar 04
4:19pm ET
Stereotaxis reports Q4 EPS (7c), consensus (7c)
Feb 23
8:45am ET
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Jan 10
5:14am ET
Stereotaxis initiated with a Buy at Roth MKM
Jan 10
3:55am ET
Stereotaxis’s Growth Trajectory: A Buy Rating with a Focus on Innovation and Expanding Markets
Jan 09
9:08am ET
Stereotaxis (STXS) Gets a Buy from Craig-Hallum
Jan 08
9:00am ET
Stereotaxis announces first patients treated using MAGiC ablation catheter
No recent press releases are available for STXS
STXS Financials
Key terms
Ad Feedback
STXS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
STXS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
